Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients

Journal of Clinical Gastroenterology

Volumn 46, Issue 5, 2012, Pages 420-426

  Jin, Young Joo ^a   Shim, Ju Hyun ^a   Chung, Young Hwa ^a   Kim, Jeong A ^a   Gi Choi, Jong ^a   Park, Won Hyung ^a   Lee, Danbi ^a   Seon Lee, Yoon ^a   Kim, Sung Eun ^b   Kim, Sung Hoon ^b   Yang, Soo Hyun ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea Veterans' Hospital   (South Korea)

Author keywords

chronic hepatitis B; hepatocellular carcinoma; HLA DRB1 allele; human leukocyte antigen

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B(E) ANTIGEN; HLA DRB1 ANTIGEN; LAMIVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; ECHOGRAPHY; GENE FREQUENCY; GENOTYPE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HLA-DRB1 CHAINS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84859887886     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318239f9cc     Document Type: Article

References (39)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543. (Pubitemid 33586866)
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917. (Pubitemid 37518510)
3. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942-1956.
4. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129-1133.
5. Koike K, Tsutsumi T, Fujie H, et al. Molecular mechanism of viral hepatocarcinogenesis. Oncology. 2002;62(Suppl 1):29-37. (Pubitemid 34702017)
6. Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin Med Assoc. 2007;70:141-145.
7. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat. 1997;4:215-220. (Pubitemid 127733427)
8. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007;85:16-23. (Pubitemid 46067317)
9. Baumert TF, Thimme R, von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol. 2007;13:82-90. (Pubitemid 46165465)
10. Singh R, Kaul R, Kaul A, et al. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol. 2007;13:1770-1787. (Pubitemid 46706009)
11. Hwang SH, Sohn YH, Oh HB, et al. Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans. Arch Pathol Lab Med. 2007;131: 117-121.
12. Liu C, Cheng B. Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese. Int J Immunogenet. 2007;34:373-378. (Pubitemid 47383396)
13. Paterson AC, Sciot R, Kew MC, et al. HLA expression in human hepatocellular carcinoma. Br J Cancer. 1988;57: 369-373.
14. Donaldson PT, Ho S, Williams R, et al. HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver. 2001;21: 143-148. (Pubitemid 32409542)
15. Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology. 2004;127:S218-S224. (Pubitemid 39423390)
16. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35: 519-524. (Pubitemid 34183954)
17. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111: 1018-1022. (Pubitemid 26327605)
18. Sayer D, Whidborne R, Brestovac B, et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens. 2001;57:46-54. (Pubitemid 32151075)
19. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355-367. (Pubitemid 26001354)
20. Hoppe B, Salama A. Sequencing-based typing of HLA. Methods Mol Med. 2007;134:71-80.
21. Bruix J, Hessheimer AJ, Forner A, et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856. (Pubitemid 43980480)
22. Watanabe Y, Aoyama N, Sakai T, et al. HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection. J Gastroenterol Hepatol. 2006;21:420-424.
23. Wu YP, Chen YL, Cao YC, et al. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer. 2006;118:3006-3011.
24. El-Chennawi FA, Auf FA, Metwally SS, et al. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunologic Invest. 2008;37:661-674.
25. Aikawa T, Kojima M, Onishi H, et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol. 1996;49:274-278. (Pubitemid 26301098)
26. Lin DY, Liaw YE, Huang CC. The distribution of HLA-A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in Taiwan. Tissue Antigens. 1987;29:110-114. (Pubitemid 17062751)
27. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. (Pubitemid 43112690)
28. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521-1531.
29. Chan HL, Tse CH, Mo F, et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol. 2008;26: 177-182.
30. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73. (Pubitemid 43042691)
31. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-422.
32. Sugimachi K, Tanaka S, Terashi T, et al. The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression. Surgery. 2002;131:S135-S141. (Pubitemid 34118629)
33. Chen MF, Hwang TL, Jeng LB, et al. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 1989;124: 1025-1028.
34. Tsuzuki T, Sugioka A, Ueda M, et al. Hepatic resection for hepatocellular carcinoma. Surgery. 1990;107:511-520. (Pubitemid 20156652)
35. Hoppe B, Heymann GA, Kiesewetter H, et al. Identification and characterization of a novel HLA-DRB1 allele, DRB10830. Tissue Antigens. 2005;66:160-162. (Pubitemid 41025943)
36. BunceM, Fanning GC,Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequencespecific primers (PCR-SSP). Tissue Antigens. 1995;45:81-90.
37. Bunce M, ONeill CM, Barnardo MCNM, et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355-367. (Pubitemid 26001354)
38. Lee KW, Jung YA. Additional sequence analysis outside exon 2 clarifies DRB1 12 and DRB1 14 allelic frequencies in Koreans. Hum Immunol. 2009;70:464-467.
39. Cano P, Klitz W, Mack SJ, et al. Common and welldocumented HLA alleles: report of the Ad-Hoc Committee of the American Society for Histocompatibility and Immunogenetics. Hum Immunol. 2007;68:392-417. (Pubitemid 46616982)